Skip to main content

Penile Ultrasound

  • Chapter
  • First Online:
Practical Urological Ultrasound

Abstract

Penile ultrasound is used commonly in the diagnostic workup of a patient with erectile dysfunction (ED), but also plays an important role by providing an anatomic and functional vascular assessment in a multitude of other conditions including Peyronie’s disease, high-flow priapism, penile fracture, penile urethral strictures, urethral stones, urethral diverticulae, or masses involving deep tissues of the penis. As a component of the evaluation for ED, penile Doppler ultrasound (PDU) is performed to assess the quality of arterial blood flow and sufficiency of veno-occlusive mechanisms, both necessary for an adequate erection. This imaging modality, which incorporates real-time imaging of the vasculature, vessel wall compliance, and blood flow dynamics in an end organ small vessel arterial system, is playing a central role in the early detection and diagnosis of otherwise silent coronary artery disease (CAD). This is an important clinical finding in men who often present with ED as their initial symptom of underlying cardiovascular disease. PDU is also an essential component of the assessment of external genitalia in trauma situations where high-flow priapism or penile fracture is suspected. Penile ultrasound provides a readily available, minimally invasive diagnostic modality that evaluates both the structural anatomy and functional hemodynamics at a reasonable cost.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Doubilet PM, Benson CB, Silverman SG, et al. The penis. Semin Ultrasound CT MR. 1991;12:157.

    CAS  PubMed  Google Scholar 

  2. Carlson BM. Human embryology and developmental biology. Philadelphia: Elsevier Health Sciences; 2013.

    Google Scholar 

  3. Moore KL, Persaud TVN, Torchia MG. The developing human. Philadelphia: Saunders; 2011.

    Google Scholar 

  4. Bellinger MF. Embryology of the male external genitalia. Urol Clin North Am. 1981;8(3):375–82.

    CAS  PubMed  Google Scholar 

  5. Sadler TW. Langman medical embryology (international ed). Auckland: Wolters Kluwer Health; 2011.

    Google Scholar 

  6. Wilson JD, George FW, Griffin JE. The hormonal control of sexual development. Science. 1981;211:1278.

    Article  CAS  PubMed  Google Scholar 

  7. Rey R, Picard JY. Embryology and endocrinology of genital development. Baillieres Clin Endocrinol Metab. 1998;12:17.

    Article  CAS  PubMed  Google Scholar 

  8. Wilson JD, Griffin JE, Leshin M, George FW. Role of gonadal hormones in development of the sexual phenotypes. Hum Genet. 1981;58:78.

    Article  CAS  PubMed  Google Scholar 

  9. Newman HF, Northup JD. Mechanism of human penile erection: an overview. Urology. 1981;17:399.

    Article  CAS  PubMed  Google Scholar 

  10. Fuchs AM, Mehringer CM, Rajfer J. Anatomy of penile venous drainage in potent and impotent men during cavernosography. J Urol. 1989;141:1353.

    CAS  PubMed  Google Scholar 

  11. Hsu GL, Hsieh CH, Wen HS, Chen YC, Chen SC, Mok MS. Penile venous anatomy: an additional description and its clinical implication. J Androl. 2003;24:921.

    Article  PubMed  Google Scholar 

  12. AUA Guidelines. http://www.auanet.org/content/guidelines-and-quality-care/policy-statements.cfm. Spring 2016

  13. Shin D, Pregenzer Jr G, Gardin JM. Erectile dysfunction: a disease marker for cardiovascular disease. Cardiol Rev. 2011;19:5.

    Article  PubMed  Google Scholar 

  14. Tomada N, Tomada I, Botelho F, et al. Are all metabolic syndrome components responsible for penile hemodynamics impairment in patients with erectile dysfunction? The role of body fat mass assessment. J Sex Med. 2011;8:831.

    Article  PubMed  Google Scholar 

  15. Corona G, Monami M, Boddi V, et al. Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. J Sex Med. 1918;7:2010.

    Google Scholar 

  16. Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170:1566.

    CAS  PubMed  Google Scholar 

  17. Hayashi T, Farrell MA, Chaput LA, et al. Lifestyle intervention, behavioral changes, and improvement in cardiovascular risk profiles in the California WISEWOMAN project. J Womens Health (Larchmt). 2010;19:1129.

    Article  Google Scholar 

  18. Miner MM. Erectile dysfunction: a harbinger or consequence: does its detection lead to a “window of curability?”. J Androl. 2011;32:125.

    Article  PubMed  Google Scholar 

  19. Inman BA, Sauver JL, Jacobson DJ, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84:108.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Billups KL, Bank AJ, Padma-Nathan H, et al. Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res. 2008;20:236.

    Article  CAS  PubMed  Google Scholar 

  21. Patel U, Lees WR. Penile sonography. In: Solibiati L, Rizzatto G, editors. Ultrasound of superficial structures. London: Churchill Livingstone; 1995. p. 229–42.

    Google Scholar 

  22. Wilkins CJ, Sriprasad S, Sidhu PS. Colour Doppler ultrasound of the penis. Clin Radiol. 2003;58:514.

    Article  CAS  PubMed  Google Scholar 

  23. Kim SH, Paick JS, Lee SE, et al. Doppler sonography of deep cavernosal artery of the penis: variation of peak systolic velocity according to sampling location. J Ultrasound Med. 1994;13:591.

    Article  CAS  PubMed  Google Scholar 

  24. Roy C, Saussine C, Tuchmann C, et al. Duplex Doppler sonography of the flaccid penis: potential role in the evaluation of impotence. J Clin Ultrasound. 2000;28:290.

    Article  CAS  PubMed  Google Scholar 

  25. Mancini M, Bartolini M, Maggi M, et al. Duplex ultrasound evaluation of cavernosal peak systolic velocity and waveform acceleration in the penile flaccid state: clinical significance in the assessment of the arterial supply in patients with erectile dysfunction. Int J Androl. 2000;23:199.

    Article  CAS  PubMed  Google Scholar 

  26. van Ahlen H, Peskar BA, Sticht G, et al. Pharmacokinetics of vasoactive substances administered into the human corpus cavernosum. J Urol. 1994;151:1227.

    PubMed  Google Scholar 

  27. Patel U, Amin Z, Friedman E, et al. Colour flow and spectral Doppler imaging after papaverine-induced penile erection in 220 impotent men: study of temporal patterns and the importance of repeated sampling, velocity asymmetry and vascular anomalies. Clin Radiol. 1993;48:18.

    Article  CAS  PubMed  Google Scholar 

  28. Broderick GA, Lue TF. The penile blood flow study: evaluation of vasculogenic impotence. In: Jonas U, Thon WF, Stief CG, editors. Erectile dysfunction. Berlin: Springer; 1991.

    Google Scholar 

  29. Shabsigh R, Fishman IJ, Shotland Y, et al. Comparison of penile duplex ultrasonography with nocturnal penile tumescence monitoring for the evaluation of erectile impotence. J Urol. 1990;143:924.

    CAS  PubMed  Google Scholar 

  30. Benson CB, Vickers MA. Sexual impotence caused by vascular disease: diagnosis with duplex sonography. AJR Am J Roentgenol. 1989;153:1149.

    Article  CAS  PubMed  Google Scholar 

  31. Lue TF, Hricak H, Marich KW, et al. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology. 1985;155:777.

    Article  CAS  PubMed  Google Scholar 

  32. Mueller SC, Lue TF. Evaluation of vasculogenic impotence. Urol Clin North Am. 1988;15:65.

    CAS  PubMed  Google Scholar 

  33. Pescatori ES, Hatzichristou DG, Namburi S, et al. A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study. J Urol. 1994;151:1209.

    CAS  PubMed  Google Scholar 

  34. Benson CB, Aruny JE, Vickers Jr MA. Correlation of duplex sonography with arteriography in patients with erectile dysfunction. AJR Am J Roentgenol. 1993;160:71.

    Article  CAS  PubMed  Google Scholar 

  35. Bassiouny HS, Levine LA. Penile duplex sonography in the diagnosis of venogenic impotence. J Vasc Surg. 1991;13:75.

    Article  CAS  PubMed  Google Scholar 

  36. Quam JP, King BF, James EM, et al. Duplex and color Doppler sonographic evaluation of vasculogenic impotence. AJR Am J Roentgenol. 1989;153:1141.

    Article  CAS  PubMed  Google Scholar 

  37. Naroda T, Yamanaka M, Matsushita K, et al. [Clinical studies for venogenic impotence with color Doppler ultrasonography—evaluation of resistance index of the cavernous artery]. Nippon Hinyokika Gakkai Zasshi. 1996;87:1231.

    CAS  PubMed  Google Scholar 

  38. Cormio L, Bettocchi C, Ricapito V, et al. Resistance index as a prognostic factor for prolonged erection after penile dynamic colour Doppler ultrasonography. Eur Urol. 1998;33:94.

    Article  CAS  PubMed  Google Scholar 

  39. Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med. 2000;30:328.

    Article  CAS  PubMed  Google Scholar 

  40. Blumentals WA, Gomez-Caminero A, Joo S, et al. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res. 2004;16:350.

    Article  CAS  PubMed  Google Scholar 

  41. Sullivan ME, Thompson CS, Dashwood MR, et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res. 1999;43:658.

    Article  CAS  PubMed  Google Scholar 

  42. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003;89:251.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Montorsi P, Montorsi F, Schulman CC. Is erectile dysfunction the “tip of the iceberg” of a systemic vascular disorder? Eur Urol. 2003;44:352.

    Article  PubMed  Google Scholar 

  44. Guay AT. The emerging link between hypogonadism and metabolic syndrome. J Androl. 2009;30:370.

    Article  CAS  PubMed  Google Scholar 

  45. Traish AM, Guay AT. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med. 2006;3:382.

    Article  CAS  PubMed  Google Scholar 

  46. Kaya C, Ergelen M, Ilktac A, Karaman MI. Impaired elasticity of aorta in patients with erectile dysfunction. Urology. 2007;70:558.

    Article  PubMed  Google Scholar 

  47. Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137:829.

    CAS  PubMed  Google Scholar 

  48. O”Kane PD, Jackson G. Erectile dysfunction: is there silent obstructive coronary artery disease? Int J Clin Pract. 2001;55:219.

    Google Scholar 

  49. Mulhall J, Teloken P, Barnas J. Vasculogenic erectile dysfunction is a predictor of abnormal stress echocardiography. J Sex Med. 2009;6:820.

    Article  PubMed  Google Scholar 

  50. Zambon JP, Mendonca RR, Wroclawski ML, et al. Cardiovascular and metabolic syndrome risk among men with and without erectile dysfunction: case-control study. Sao Paulo Med J. 2010;128:137.

    Article  PubMed  Google Scholar 

  51. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113.

    Article  PubMed  Google Scholar 

  52. Bohm M, Baumhakel M, Teo K, et al. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation. 2010;121:1439.

    Article  PubMed  Google Scholar 

  53. Batty GD, Li Q, Czernichow S, et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol. 2010;56:1908.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Kang BC, Lee DY, Byun JY, et al. Post-traumatic arterial priapism: colour Doppler examination and superselective arterial embolization. Clin Radiol. 1998;53:830.

    Article  CAS  PubMed  Google Scholar 

  55. Asgari MA, Hosseini SY, Safarinejad MR, et al. Penile fractures: evaluation, therapeutic approaches and long-term results. J Urol. 1996;155:148.

    Article  CAS  PubMed  Google Scholar 

  56. El-Bahnasawy MS, Gomha MA. Penile fractures: the successful outcome of immediate surgical intervention. Int J Impot Res. 2000;12:273.

    Article  CAS  PubMed  Google Scholar 

  57. Atan A, Gungor S, Ozergin O, et al. Idiopathic penile mondors’ disease: a case report. Int Urol Nephrol. 2002;34:97.

    Article  PubMed  Google Scholar 

  58. Dicuio M, Pomara G, Ales V, et al. Doppler ultrasonography in a young patient with penile Mondor’s disease. Arch Ital Urol Androl. 2005;77:58.

    PubMed  Google Scholar 

  59. Sasso F, Gulino G, Basar M, et al. Penile Mondors’ disease: an underestimated pathology. Br J Urol. 1996;77:729.

    Article  CAS  PubMed  Google Scholar 

  60. Nachmann MM, Jaffe JS, Ginsberg PC, et al. Sickle cell episode manifesting as superficial thrombophlebitis of the penis. J Am Osteopath Assoc. 2003;103:102.

    PubMed  Google Scholar 

  61. Luzzi GA, Pattinson J, Wathen CG. Penile Mondor’s disease and inherited thrombophilia. Int J STD AIDS. 2006;17:70.

    Article  CAS  PubMed  Google Scholar 

  62. Brock G, Hsu GL, Nunes L, et al. The anatomy of the tunica albuginea in the normal penis and Peyronie’s disease. J Urol. 1997;157:276.

    Article  CAS  PubMed  Google Scholar 

  63. Chou YH, Tiu CM, Pan HB, et al. High-resolution real-time ultrasound in Peyronie’s disease. J Ultrasound Med. 1987;6:67.

    Article  CAS  PubMed  Google Scholar 

  64. Kadioglu A, Tefekli A, Erol H, et al. Color Doppler ultrasound assessment of penile vascular system in men with Peyronie’s disease. Int J Impot Res. 2000;12:263.

    Article  CAS  PubMed  Google Scholar 

  65. Morana C, Loiero G, Sangiorgio A, Zani T, Catalano G. Elastosonography in the Peyronie’s disease: our preliminary experience. Arch Ital Urol Androl. 2010;82:269–70.

    PubMed  Google Scholar 

  66. Riversi V, Tallis V, Trovatelli S, et al. Realtime-elastosonography of the penis in patients with Peyronie’s disease. Arch Ital Urol Androl. 2012;84:174.

    PubMed  Google Scholar 

  67. Richards G, Goldenberg E, Pek H, Gilbert BR. Penile sonoelastography for the localization of a non-palpable, non-sonographically visualized lesion in a patient with penile curvature from Peyronie’s disease. J Sex Med. 2014;11:516.

    Article  PubMed  Google Scholar 

  68. Zhang J, Qiao X, Gao F, et al. A new method of measuring the stiffness of corpus cavernosum penis with ShearWave™ Elastography. Br J Radiol. 2015;88:1048.

    Google Scholar 

  69. Horenblas S, Kroger R, Gallee MP, et al. Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging? A comparison of ultrasound with histopathology. Urology. 1994;43:702.

    Article  CAS  PubMed  Google Scholar 

  70. Lont AP, Besnard AP, Gallee MP, et al. A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int. 2003;91:493.

    Article  CAS  PubMed  Google Scholar 

  71. Lan SK, Lin CW, Ho HC, et al. Penile metastasis secondary to nasal NK/T-cell lymphoma. Urology. 2008;72:1014.

    Article  PubMed  Google Scholar 

  72. Gallentine ML, Morey AF. Imaging of the male urethra for stricture disease. Urol Clin North Am. 2002;29:361.

    Article  PubMed  Google Scholar 

  73. Morey AF, McAninch JW. Role of preoperative sonourethrography in bulbar urethral reconstruction. J Urol. 1997;158:1376.

    Article  CAS  PubMed  Google Scholar 

  74. Choudhary S, Singh P, Sundar E, et al. A comparison of sonourethrography and retrograde urethrography in evaluation of anterior urethral strictures. Clin Radiol. 2004;59:736.

    Article  CAS  PubMed  Google Scholar 

  75. Morey AF, McAninch JW. Sonographic staging of anterior urethral strictures. J Urol. 2000;163:1070.

    Article  CAS  PubMed  Google Scholar 

  76. Kim B, Kawashima A, LeRoy AJ. Imaging of the male urethra. Semin Ultrasound CT MR. 2007;28:258.

    Article  PubMed  Google Scholar 

  77. Bearcroft PW, Berman LH. Sonography in the evaluation of the male anterior urethra. Clin Radiol. 1994;49:621.

    Article  CAS  PubMed  Google Scholar 

  78. Rastrelli G, Corona G, Mannucci E, Maggi M. Vascular and chronological age in men with erectile dysfunction: a longitudinal study. J Sex Med. 2016;13:200.

    Article  PubMed  Google Scholar 

  79. Rastrelli G, Corona G, Lotti F, et al. Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors. J Sex Med. 2014;11:173.

    Article  PubMed  Google Scholar 

  80. Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, et al. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and metaanalysis of cohort studies. Circ Cardiovasc Qual Outcomes. 2013;6:99.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Soroush Rais-Bahrami M.D. .

Editor information

Editors and Affiliations

Appendices

Appendix 1: A Sample Report Template for a Penile Doppler Ultrasound Performed as a Diagnostic Element in a Case of Erectile Dysfunction

Suggested protocol for evaluation of erectile dysfunction:

DORSAL view is primary, VENTRAL view as needed (indicate which view is used on image)

Pre-injection (also Images for non-injection penile ultrasound studies)

 1. Longitudinal and transverse survey scan of the phallus with cine loops

 2. Split screen base, mid, and distal view of phallus in transverse plane

 3. Split screen longitudinal view of left and right corpora cavernosa

 4. Flaccid phallus (image taken in mid 2/3 of exposed phallus):

  (a) AP and width of each corpora

  (b) Inner diameter measurements of left and right cavernosal artery at mid phallus

  (c) Spectral Doppler waveform with PSV, EDV, and Ri

  (d) Optional measurements: acceleration time, pulsatility index, velocity index

Post-injection

 1. 5 and 10 min

  (a) Spectral Doppler waveform with PSV, EDV, and Ri

  (b) Inner diameter measurements of left and right cavernosal artery at mid phallus

  (c) Optional measurements: acceleration time, pulsatility index, velocity index

  (d) Subjective evaluation of tumescence and rigidity

 2. 15 and 20 min (second injection if indicated, document total dose)

  (a) Spectral Doppler waveform with PSV, EDV, and Ri

  (b) Inner diameter measurements of left and right cavernosal artery at mid phallus

  (c) Optional measurements: acceleration time, pulsatility index, velocity index

  (d) Subjective evaluation of tumescence and rigidity

 3. 25 and 30 min (third injection if indicated, document total dose)

  (a) Spectral Doppler waveform with PSV, EDV, and Ri

  (b) Inner diameter measurements of left and right cavernosal artery at mid phallus

  (c) Optional measurements: acceleration time, pulsatility index, velocity index

  (d) Subjective evaluation of tumescence and rigidity

 4. End of study

  (a) Inner diameter measurements of left and right cavernosal artery and mid phallus

Appendix 2: Patient Instructions for Penile Injection Therapy

Preparation for Injection

Items You Will Need

  • Alcohol sponges or swaps.

  • One milliliter insulin syringe with #28 or #30 gauge needle. These are disposable and not to be reused for a second injection. Disposal should be performed with the cap on the needle so as not to injure anyone disposing of trash.

  • Papaverine/Phentolamine combination, Prostaglandin E1 or Papaverine/Phentolamine/Prostaglandin combination either pre-drawn by the physician a pharmacist in the syringe, or in a vial to be drawn into the syringe by the patient in the appropriate volume as prescribed by the physician. The medication must be refrigerated and away from light exposure.

Filling the Syringe

  1. 1.

    Check the expiration date of medication. Hold the medication bottle so that your fingers do not touch the rub or stopper (Fig. 7.22).

    figure 22

    Fig. 7.22

  2. 2.

    Using a circular motion, wipe off the top of the bottle with alcohol swab (Fig. 7.23).

    figure 23

    Fig. 7.23

  3. 3.

    Remove the needle cover. Do not allow the needle to touch anything before drawing the medication or before injecting the medication (Fig. 7.24).

    figure 24

    Fig. 7.24

  4. 4.

    Draw a small amount of the air into the syringe to be injected into the medication vial. The syringe needle should be inserted into the center of the rubber stopper of the medication vial. Push the air into the bottle (Fig. 7.25).

    figure 25

    Fig. 7.25

  5. 5.

    Turn the bottle and syringe upside down. Solely draw the medication into the syringe. Tap the syringe gently to remove the bubbles (Fig. 7.26).

    figure 26

    Fig. 7.26

  6. 6.

    Move the plunger in and out several times while gently tapping the syringe, just removing all air bubbles (Fig. 7.27).

    figure 27

    Fig. 7.27

  7. 7.

    Gently remove the syringe from the medication vial and replace the needle cap over the needle. Keep the protected needle on the filled syringe within easy reach prior to injection (Fig. 7.28).

    figure 28

    Fig. 7.28

Self-Injection Technique

  • Step 1: Grasp the head of the penis, not the skin, and hold upwards toward the trunk. Position the penis along your inner thigh. Choose the injection site on the side of the penis. Avoid injecting into any visible veins. The crossed hatched areas in the figure below represent the ideal locations to inject into (Fig. 7.29).

    figure 29

    Fig. 7.29

  • Step 2: Wipe the skin with an alcohol swab (Fig. 7.30).

    figure 30

    Fig. 7.30

  • Step 3: Pick up the syringe between the thumb and middle finger, like a pen, and push the needle gently but firmly through the skin until the entire needle is buried inside the penis (Fig. 7.31).

    figure 31

    Fig. 7.31

  • Step 4: Holding the syringe, use your thumb to slowly (8–10 s) inject the entire amount of medication. Then remove the needle from your penis (Fig. 7.32).

    figure 32

    Fig. 7.32

  • Step 5: Immediately apply pressure on the injection site with another alcohol wipe for at least 2 min. Make sure there is no bleeding (Fig. 7.33).

    figure 33

    Fig. 7.33

  • Step 6: Dispose of the syringe unit into the puncture-proof receptacle provided.

  • Step 7: Stand up to allow your erection to develop quickly. You are now ready to start sexual foreplay. You will have a full or action within a few minutes.

Normally, the erection will last anywhere from 30 to 120 min. If your erection lasts longer than 3 h, you should seek immediate medical attention.

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rais-Bahrami, S., Richards, G., Gilbert, B.R. (2017). Penile Ultrasound. In: Fulgham, P., Gilbert, B. (eds) Practical Urological Ultrasound. Current Clinical Urology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-43868-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43868-9_7

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-43867-2

  • Online ISBN: 978-3-319-43868-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics